Archipel Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Archipel Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$285K	Buy	+1,774	New	+$273K	0.08%	127

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Archipel Asset Management's JAZZ Position: Q3 2014 in Review

Archipel Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2014: 1,774 shares worth $285K. The stake represents 0.08% of the portfolio and ranks #127 among its holdings.

325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

Archipel Asset Management held 1,774 shares of Jazz Pharmaceuticals worth $285K as of Q3 2014.
Jazz Pharmaceuticals was a new Archipel Asset Management position in Q3 2014.
Jazz Pharmaceuticals made up 0.08% of Archipel Asset Management's portfolio in Q3 2014, its #127 holding.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Archipel Asset Management's 13F filing for Q3 2014, filed 15 Oct 2014.